ClinicalTrials.gg
CompletedNCT07650461Updated Jun 16, 2026

Enhanced Recovery Versus Standard Care After Emergency Abdominal Surgery in Patients Requiring Emergency Laparotomy

An interventional study of Enhanced Recovery After Surgery and Conventional Postoperative Care in Emergency Laparotomy, Intestinal Obstruction and Intestinal Perforation, sponsored by Recep Tayyip Erdogan Hospital Pakistan - Muzaffargarh. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Recep Tayyip Erdogan Hospital Pakistan - Muzaffargarh · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled May 2025, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to compare an Enhanced Recovery After Surgery (ERAS) protocol with conventional postoperative care in adults undergoing emergency laparotomy for intestinal obstruction or intestinal perforation.

The main question this study aims to answer is:

  • Does the ERAS protocol reduce surgical site infections compared with conventional care after emergency laparotomy?

Researchers will also compare other recovery outcomes between the two groups, including length of hospital stay, occurrence of paralytic ileus (temporary loss of bowel function), time to first bowel movement, and time to start taking fluids by mouth after surgery.

A total of 102 participants will be enrolled and randomly assigned to one of two groups. One group will receive postoperative care according to the ERAS protocol, while the other group will receive conventional postoperative care. All participants will undergo emergency laparotomy using standard surgical and anesthetic techniques.

Participants will:

  • Undergo emergency laparotomy for intestinal obstruction or intestinal perforation.
  • Receive either ERAS-based postoperative care or conventional postoperative care.
  • Be monitored during their hospital stay for recovery and postoperative complications.
  • Be assessed for bowel function recovery, ability to tolerate oral fluids, and length of hospital stay.
  • Be followed for 30 days after surgery to determine whether a surgical site infection develops.

The researchers hypothesize that patients managed with the ERAS protocol will have a lower frequency of surgical site infections and improved postoperative recovery compared with those receiving conventional care.

02

Conditions studied

  • Emergency Laparotomy
  • Intestinal Obstruction
  • Intestinal Perforation
  • Enhanced Recovery After Surgery (ERAS) Protocol
  • Surgical Site Infection (SSI)
  • Postoperative Recovery

Keywords

  • Enhanced Recovery After Surgery
  • Emergency Laparotomy
  • Surgical Site Infection
  • Postoperative complications
  • Intestinal Obstruction
  • Intestinal Perforation
  • Length of Hospital Stay
  • Postoperative Ileus
03

In context

Intestinal Obstruction

104 studies on the registry are indexed under Intestinal Obstruction; 15 are open to participants now.

This study's enrollment of 102 is above the median of 62 across 54 interventional studies indexed under Intestinal Obstruction.

Browse Intestinal Obstruction studies →

Lead sponsor

Recep Tayyip Erdogan Hospital Pakistan - Muzaffargarh is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • acute intestinal obstruction or intestinal perforation
  • planned for emergency laparotomy

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Patients on chronic
  • Malignant ulcers confirmed by histopathological examination
  • laparoscopic surgeries
  • Acute abdominal trauma
  • Patients who require postoperative intensive care unit (ICU) care
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
102 participants (actual)

Study arms

  • Experimental
    ERAS Protocol Group

    Participants undergoing emergency laparotomy will receive postoperative care according to the Enhanced Recovery After Surgery (ERAS) protocol.

    Procedure: Enhanced Recovery After Surgery

  • Active comparator
    Conventional Care Group

    Participants undergoing emergency laparotomy will receive standard postoperative care as routinely practiced in the surgical unit.

    Procedure: Conventional Postoperative Care

Interventions

  • ProcedureEnhanced Recovery After Surgery

    A standardized multimodal perioperative care pathway applied to patients undergoing emergency laparotomy. The protocol includes pre-defined components for preoperative optimization, intraoperative management, and postoperative care. Postoperative elements include early mobilization, early initiation of oral fluids and diet, optimized multimodal analgesia, early removal of tubes/drains when appropriate, and structured fluid management.

  • ProcedureConventional Postoperative Care

    Standard postoperative management routinely practiced in the surgical unit for patients undergoing emergency laparotomy. Care includes traditional postoperative monitoring, routine analgesia, delayed initiation of oral intake, standard mobilization practices, and conventional fluid and supportive management.

06

What researchers measure

Primary outcomes

  1. Surgical Site Infection

    Frequency of surgical site infection (superficial and deep) occurring within 30 days after emergency laparotomy will be assessed and compared between the Enhanced Recovery After Surgery (ERAS) group and the conventional care group. Surgical site infection will be defined and classified according to standard surgical infection criteria as specified in the study protocol

    Time frame: From enrollment within 30 days postoperatively

Other outcomes

  1. Hospital Stay

    Length of hospital stay will be measured in days from the day of surgery until final disposition (discharge or death).

    Time frame: From surgery to discharge within 30 days

  2. Paralytic Ileus

    Incidence of postoperative paralytic ileus defined as presence of abdominal distension with absence of bowel sounds on clinical examination (auscultation for at least one minute).

    Time frame: From surgery till hospital stay within 30 days postoperatively

  3. Time to First Stool

    Time (in days) from surgery to passage of first postoperative stool, indicating return of bowel function.

    Time frame: From surgery till hospital stay until discharge within 30 days postoperatively

  4. Time to First Fluid Diet

    Time (in days) from surgery to initiation and tolerance of first oral fluid intake postoperatively.

    Time frame: Postoperatively during hospital stay till discharge within 30 days postoperatively

07

Study locations

1 site
  • Recep Tayyip Erdogan Hospital Muzaffargarh
    Muzaffargarh, Punjab Province 34200, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07650461
Lead sponsor
Recep Tayyip Erdogan Hospital Pakistan - Muzaffargarh
Responsible party
Sarfraz Hussain (Principal Investigator, Recep Tayyip Erdogan Hospital Pakistan - Muzaffargarh) — Principal investigator
First posted
Jun 16, 2026
Start date
May 1, 2025
Primary completion
Oct 30, 2025
Completion
Oct 30, 2025
Last update
Jun 16, 2026

Study contacts

Muhammad I Seerat, FCPS
study chair · Recep tayyip Erdogan Hospital Muzaffargarh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion